戻る
Innovent Biologics, Inc. (1801.HK)価格
1801.HK 株価推移チャート
INNOVENT BIO (1801.HK)
Innovent Biologics, Inc.
HK$83.25
-2.17%
$-1.84
休場: Jan 20, 16:00:00 HKT
主要データ
前終値
$85.35
始値
$85.1
当日レンジ
$82.75 - $86.05
52週レンジ
$30.75 - $109.1
取引高
6.0M
平均取引高
14.1M
1株当たり利益(TTM)
0.74
配当利回り
--
時価総額
$143.2B
INNOVENT BIOとは何ですか？
Innovent Biologics, Inc. is a biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases. The company is headquartered in Suzhou, Jiangsu and currently employs 6,190 full-time employees. The company went IPO on 2018-10-31. The pipeline covering monoclonal antibodies, multi-specific antibodies, immuno-cytokine, antibody-drug conjugates (ADCs), cell therapy and small molecules. The Company’s main products include TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), Pemazyre (pemigatinib) and others. The firm mainly conducts its businesses within domestic and overseas markets.